[Effects of PGA 1 on immune response in mice with melanoma B 16].
This study evaluated the effects of PGA1 on B 16 melanoma bearing mice. PGA1 was observed to inhibit the rate of melanoma growth, both as delay in the rate of appearance and decrease in tumor volume. Furthermore PGA1 stimulated humoral but not cellular immune response in melanoma bearing mice, while it was ineffective in normal mice.
D000818:Animals; D005260:Female; D006084:Graft Rejection; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000209:etiology; D008545:Melanoma / Q000150:complications / Q000188:drug therapy*; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011454:Prostaglandins A / Q000627:therapeutic use*; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D011454:Prostaglandins A
Effetti delle PGA 1 sulla risposta immunitaria in topi porttori di melanoma B 16.